Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Exchange Rate Effect (2022 - 2025)

Gossamer Bio's Exchange Rate Effect history spans 4 years, with the latest figure at $2000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 101.6% year-over-year to $2000.0; the TTM value through Dec 2025 reached $141000.0, up 238.24%, while the annual FY2025 figure was $141000.0, 238.24% up from the prior year.
  • Exchange Rate Effect reached $2000.0 in Q4 2025 per GOSS's latest filing, up from -$95000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $635000.0 in Q4 2022 to a low of -$533000.0 in Q2 2022.
  • Average Exchange Rate Effect over 4 years is -$23000.0, with a median of -$13500.0 recorded in 2023.
  • The largest YoY upside for Exchange Rate Effect was 1712.5% in 2025 against a maximum downside of 202.15% in 2025.
  • A 4-year view of Exchange Rate Effect shows it stood at $635000.0 in 2022, then tumbled by 69.61% to $193000.0 in 2023, then crashed by 164.77% to -$125000.0 in 2024, then soared by 101.6% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Exchange Rate Effect are $2000.0 (Q4 2025), -$95000.0 (Q3 2025), and $129000.0 (Q2 2025).